Home PD, Aroda VR, Blonde L, Guyot P, et al. Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon-like peptide-1 receptor agonists (GLP-1RAs): a systematic literature review and indirect treatment comparison. Diabetes Obes Metab 2020 Jul 6. doi: 10.1111/dom.14136.
PMID: 32627297